TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial.

A Jatoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.